NCT07148167

Brief Summary

In the literature, we found only one study evaluating the thickness of the cervical paraspinal muscles (multifidus, semispinalis cervicis, semispinalis capitis, splenius capitis, and trapezius) in patients with AS. This study examined the morphology of all neck extensor muscles (multifidus, semispinalis capitis, semispinalis cervicis, splenius capitis, and trapezius muscles) using ultrasound and their relationship to activities of daily living and compared them with a control group. As is well known, the user's experience is crucial in ultrasound. Furthermore, ultrasound cannot accurately assess the deep paravertebral muscles. Therefore, inspired by this study, we decided to use Magnetic Resonance Imaging (MRI) to evaluate the cervical muscle planes in AS patients in more detailed and objective ways. In this study, in addition to cervical muscle volumes in AS patients, we also aimed to evaluate cervical fat infiltration and cervical alignment, which have not been previously evaluated in AS patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
158

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 14, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 29, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

February 20, 2026

Status Verified

February 1, 2026

Enrollment Period

11 months

First QC Date

July 14, 2025

Last Update Submit

February 18, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • servical MRI fındings in AS patients,

    the cervical muscle planes, cervical muscle volumes in AS patients cervical fat infiltration

    Patients who underwent cervical MRI between January 2020 and September 2023

Study Arms (2)

Ankylosing Spondylitis group

For the study group: * Patients diagnosed with ankylosing spondylitis, aged 18-50. * Patients who underwent a cervical MRI between January 2020 and September 2023.

Other: Magnetic resonance imaging

Control Group

Patients aged 18-50 who underwent cervical MRI between January 2020 and September 2023 due to nonspecific neck pain, who did not have an AS diagnosis and whose cervical MRI was reported as normal.

Other: Magnetic resonance imaging

Interventions

use Magnetic Resonance Imaging (MRI) to evaluate the cervical muscle planes in AS patients in more detailed and objective ways. In this study, in addition to cervical muscle volumes in AS patients, we also aimed to evaluate cervical fat infiltration and cervical alignment, which have not been previously evaluated in AS patients.

Ankylosing Spondylitis groupControl Group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

For the study group: * Patients diagnosed with ankylosing spondylitis, aged 18-50. * Patients who underwent a cervical MRI between January 2020 and September 2023. Control Group Patients aged 18-50 who underwent cervical MRI between January 2020 and September 2023 due to nonspecific neck pain, who did not have an AS diagnosis and whose cervical MRI was reported as normal.

You may qualify if:

  • For the study group:
  • Patients diagnosed with ankylosing spondylitis, aged 18-50.
  • Patients who underwent a cervical MRI between January 2020 and September 2023. Control Group Patients aged 18-50 who underwent cervical MRI between January 2020 and September 2023 due to nonspecific neck pain, who did not have an AS diagnosis and whose cervical MRI was reported as normal.

You may not qualify if:

  • Patients over 50 years of age
  • History of spine surgery;
  • Presence of pain, numbness, and weakness in the upper extremities
  • History of cervical injury or neck injury
  • Presence of tuberculosis, tumor, fracture, infection, instability, cervical myelopathy, cervical disc herniation (protrusion, extrusion) (will be considered cervical bulging)
  • Presence of cervical radiculopathy
  • Those with a detectable pathological spinal condition related to neck pain, including spinal deformity; inflammatory or rheumatic diseases other than AS, malignancies, or neurological diseases
  • A cognitive or psychological disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kayseri City Hospital

Kayseri, Kocasinan, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Magnetic Resonance Spectroscopy

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Target Duration
1 Month
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

July 14, 2025

First Posted

August 29, 2025

Study Start

January 1, 2025

Primary Completion

November 30, 2025

Study Completion

November 30, 2025

Last Updated

February 20, 2026

Record last verified: 2026-02

Locations